company background image
IME

ImExHSASX:IME Stock Report

Market Cap

AU$43.7m

7D

-4.0%

1Y

-24.0%

Updated

17 Oct, 2021

Data

Company Financials +
IME fundamental analysis
Snowflake Score
Valuation1/6
Future Growth6/6
Past Performance0/6
Financial Health5/6
Dividends0/6

IME Overview

ImExHS Limited operates as an imaging software as a service and ancillary service provider in Australia and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for ImExHS
Historical stock prices
Current Share PriceAU$1.33
52 Week HighAU$1.32
52 Week LowAU$2.54
Beta1.29
1 Month Change-8.28%
3 Month Change-21.77%
1 Year Change-24.00%
3 Year Change-14.19%
5 Year Changen/a
Change since IPO-1.48%

Recent News & Updates

Mar 19
Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)

Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)

ImExHS Limited ( ASX:IME ) is possibly approaching a major achievement in its business, so we would like to shine some...

Shareholder Returns

IMEAU Healthcare ServicesAU Market
7D-4.0%0.2%0.9%
1Y-24.0%46.7%20.2%

Return vs Industry: IME underperformed the Australian Healthcare Services industry which returned 46.7% over the past year.

Return vs Market: IME underperformed the Australian Market which returned 20.2% over the past year.

Price Volatility

Is IME's price volatile compared to industry and market?
IME volatility
IME Beta1.29
Industry Beta0.49
Market Beta1

Stable Share Price: IME is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: IME's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012n/aGerman Arangohttps://www.imexhs.com

ImExHS Limited operates as an imaging software as a service and ancillary service provider in Australia and internationally. It is involved in developing and selling Hiruko software platform that comprises radiology information system, which manages the workflow management system with a patient data and image distribution system, as well as picture archiving and communication system that allows healthcare organization to capture, store, view, and share radiology images. The company was founded in 2012 and is headquartered in Mascot, Australia.

ImExHS Fundamentals Summary

How do ImExHS's earnings and revenue compare to its market cap?
IME fundamental statistics
Market CapAU$43.70m
Earnings (TTM)-AU$4.03m
Revenue (TTM)AU$11.65m

3.8x

P/S Ratio

-10.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IME income statement (TTM)
RevenueAU$11.65m
Cost of RevenueAU$6.97m
Gross ProfitAU$4.68m
ExpensesAU$8.71m
Earnings-AU$4.03m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.12
Gross Margin40.14%
Net Profit Margin-34.58%
Debt/Equity Ratio7.5%

How did IME perform over the long term?

See historical performance and comparison

Valuation

Is ImExHS undervalued compared to its fair value and its price relative to the market?

3.2x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate IME's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate IME's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: IME is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: IME is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IME's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IME is good value based on its PB Ratio (3.2x) compared to the AU Healthcare Services industry average (3.8x).


Future Growth

How is ImExHS forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

106.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IME is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: IME is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IME's is expected to become profitable in the next 3 years.

Revenue vs Market: IME's revenue (34.2% per year) is forecast to grow faster than the Australian market (5.5% per year).

High Growth Revenue: IME's revenue (34.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IME's Return on Equity is forecast to be high in 3 years time (23.7%)


Past Performance

How has ImExHS performed over the past 5 years?

-27.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IME is currently unprofitable.

Growing Profit Margin: IME is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: IME is unprofitable, and losses have increased over the past 5 years at a rate of 27.3% per year.

Accelerating Growth: Unable to compare IME's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IME is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (39.5%).


Return on Equity

High ROE: IME has a negative Return on Equity (-29.51%), as it is currently unprofitable.


Financial Health

How is ImExHS's financial position?


Financial Position Analysis

Short Term Liabilities: IME's short term assets (A$13.1M) exceed its short term liabilities (A$3.9M).

Long Term Liabilities: IME's short term assets (A$13.1M) exceed its long term liabilities (A$1.4M).


Debt to Equity History and Analysis

Debt Level: IME's debt to equity ratio (7.5%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if IME's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IME has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: IME has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 31.7% each year.


Dividend

What is ImExHS current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IME's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IME's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IME's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IME's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IME's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

German Arango

3.17yrs

Tenure

AU$367,975

Compensation

Dr. German Arango is Chief Executive Officer and Managing Director at ImExHS Limited since August 28, 2018. Dr. Arango has been a Director of ImExHS Limited (formerly known as Omni Market Tide Ltd.) since...


CEO Compensation Analysis

Compensation vs Market: German's total compensation ($USD273.12K) is about average for companies of similar size in the Australian market ($USD302.72K).

Compensation vs Earnings: German's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: IME's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

Experienced Board: IME's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: IME insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 37.8%.


Top Shareholders

Company Information

ImExHS Limited's employee growth, exchange listings and data sources


Key Information

  • Name: ImExHS Limited
  • Ticker: IME
  • Exchange: ASX
  • Founded: 2012
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$43.705m
  • Shares outstanding: 32.86m
  • Website: https://www.imexhs.com

Number of Employees


Location

  • ImExHS Limited
  • 122 O’Riordan Street
  • Mascot
  • New South Wales
  • 2020
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/17 07:04
End of Day Share Price2021/10/15 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.